The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Matrix metalloproteinase proteomics: substrates, targets, and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinases and the regulation of tissue remodelling
Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Self-citationMatrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A. G., Clark-Lewis, I., & Overall, C. M. (2000) · Science · doi:10.1126/science.289.5482.1202 · Cited by 772
Self-citationZhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., & López-Otín, C. (2003) · Nature Genetics · doi:10.1038/ng1249 · Cited by 536
Self-citationMatrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen
Xu, X., Wang, Y., Chen, Z., Sternlicht, M. D., Hidalgo, M., & Steffensen, B. (2005) · Cancer Research · doi:10.1158/0008-5472.130.65.1 · Cited by 413
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., Frans, N., Chang, E., Tao, Q., Vanhove, M., Lejeune, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3255 · Cited by 355
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Self-citationSMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion
Kitamura, T., Kometani, K., Hashida, H., Matsunaga, A., Miyoshi, H., Hosogi, H., Aoki, M., Oshima, M., Hattori, M., Takabayashi, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1997 · Cited by 285
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
Dean, R. A., Cox, J. H., Bellac, C. L., Doucet, A., Starr, A. E., & Overall, C. M. (2008) · Blood · doi:10.1182/blood-2007-12-129080 · Cited by 257
Self-citationMolet, S., Belleguic, C., Lena, H., Germain, N., Bertrand, C. P., Shapiro, S. D., Planquois, J. M., Delaval, P., & Lagente, V. (2005) · Inflammation Research · doi:10.1007/s00011-004-1319-4 · Cited by 252
Matrix Metalloproteinases as Valid Clinical Target
Fingleton, B. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207779313551 · Cited by 246
Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S., & Overall, C. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305862101 · Cited by 244
Self-citationDean, R. A., & Overall, C. M. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600341-mcp200 · Cited by 233
Self-citationStructural Basis for the Highly Selective Inhibition of MMP-13
Engel, C. K., Pirard, B., Schimanski, S., Kirsch, R., Habermann, J., Klingler, O., Schlotte, V., Weithmann, K. U., & Wendt, K. U. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.014 · Cited by 228
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Aikawa, Y., Morimoto, K., Yamamoto, T., Chaki, H., Hashiramoto, A., Narita, H., Hirono, S., & Shiozawa, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1412 · Cited by 214
Tian, M., Cui, Y.-Z., Song, G.-H., Zong, M.-J., Zhou, X.-Y., Chen, Y., & Han, J.-X. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-241 · Cited by 214
Johnson, A. R., Pavlovsky, A. G., Ortwine, D. F., Prior, F., Man, C.-F., Bornemeier, D. A., Banotai, C. A., Mueller, W. T., McConnell, P., Yan, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703286200 · Cited by 212
LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity
Tester, A. M., Cox, J. H., Connor, A. R., Starr, A. E., Dean, R. A., Puente, X. S., López-Otín, C., & Overall, C. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000312 · Cited by 210
Self-citationCorry, D. B., Kiss, A., Song, L.-Z., Song, L., Xu, J., Lee, S.-H., Werb, Z., & Kheradmand, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-1412fje · Cited by 209
Gutiérrez-Fernández, A., Fueyo, A., Folgueras, A. R., Garabaya, C., Pennington, C. J., Pilgrim, S., Edwards, D. R., Holliday, D. L., Jones, J. L., Span, P. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5154 · Cited by 207
Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2502 · Cited by 200
Dean, R. A., Butler, G. S., Hamma-Kourbali, Y., Delbé, J., Brigstock, D. R., Courty, J., & Overall, C. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-07 · Cited by 196
Self-citationIliopoulos, D., Malizos, K. N., & Tsezou, A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.069377 · Cited by 190
MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization
Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A., Libert, C., Krell, H.-W., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0113fje · Cited by 189
Matrix metalloproteinases and bone
Krane, S. M., & Inada, M. (2008) · Bone · doi:10.1016/j.bone.2008.03.020 · Cited by 183
Greenlee, K. J., Corry, D. B., Engler, D. A., Matsunami, R. K., Tessier, P., Cook, R. G., Werb, Z., & Kheradmand, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7312 · Cited by 182
Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases
Houghton, A. M., Grisolano, J. L., Baumann, M. L., Kobayashi, D. K., Hautamaki, R. D., Nehring, L. C., Cornelius, L. A., & Shapiro, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-0297 · Cited by 178
Butler, G. S., Dean, R. A., Tam, E. M., & Overall, C. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01775-07 · Cited by 162
Self-citationNovel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach
Xu, D., Suenaga, N., Edelmann, M. J., Fridman, R., Muschel, R. J., & Kessler, B. M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800095-mcp200 · Cited by 162
Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma
Palavalli, L. H., Prickett, T. D., Wunderlich, J. R., Wei, X., Burrell, A. S., Porter-Gill, P., Davis, S., Wang, C., Cronin, J. C., Agrawal, N. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.340 · Cited by 161
Stage-Specific Action of Matrix Metalloproteinases Influences Progressive Hereditary Kidney Disease
Zeisberg, M., Khurana, M., Rao, V. H., Cosgrove, D. E., Rougier, J., Werner, M. C., Shield, C. F., Werb, Z., & Kalluri, R. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030100 · Cited by 154
Pfeifer, A., Keßler, T., Silletti, S., Cheresh, D. A., & Verma, I. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220399597 · Cited by 151
Doucet, A., Butler, G. S., Rodriáguez, D., Prudova, A., & Overall, C. M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800012-mcp200 · Cited by 150
Self-citationMutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice
Oh, J., Takahashi, R., Adachi, E., Kondo, S., Kuratomi, S., Noma, A., Alexander, D. B., Motoda, H., Okada, A., Seiki, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207688 · Cited by 142
Tam, E. M., Moore, T. R., Butler, G. S., & Overall, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407186200 · Cited by 142
Self-citationMartin, M. D., Carter, K. J., Jean-Philippe, S. R., Chang, M., Mobashery, S., Thiolloy, S., Lynch, C. C., Matrisian, L. M., & Fingleton, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0537 · Cited by 134
A novel intracellular role of matrix metalloproteinase‐3 during apoptosis of dopaminergic cells
Choi, D. H., Kim, E., Son, H. J., JOH, T. H., Kim, Y. S., Kim, D., Beal, M. F., & Hwang, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05399.x · Cited by 125
Pendás, A. M., Folgueras, A. R., Llano, E., Caterina, J. J., Frerard, F., Rodríguez, F. J., Astudillo, A., Noël, A., Birkedal‐Hansen, H., & López-Otín, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5304-5313.2004 · Cited by 111
Radisky, D. C., Stallings‐Mann, M. L., Hirai, Y., & Bissell, M. J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2633 · Cited by 105
Li, W. M., Li, J., Wu, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900093d · Cited by 104
MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease
Szabova, L., Chrysovergis, K., Yamada, S. S., & Holmbeck, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210982 · Cited by 104
Quément, C. L., Guénon, I., Gillon, J., Valença, S. S., Cayron-Elizondo, V., Lagente, V., & Boichot, E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.180 · Cited by 101
Golubkov, V. S., Boyd, S. E., Savinov, A. Y., Chekanov, A. V., Osterman, A. L., Remacle, A. G., Rozanov, D. V., Doxsey, S., & Strongin, A. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502779200 · Cited by 101
A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma
Hwang, I. K., Park, S., Kim, S. Y., & Lee, S. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.08.001 · Cited by 97
Roeb, E., Schleinkofer, K., Kernebeck, T., Pötsch, S., Jansen, B., Behrmann, I., Matern, S., & Grötzinger, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207446200 · Cited by 96
MMP-9 Sheds the β2 Integrin Subunit (CD18) from Macrophages
Vaisar, T., Kassim, S. Y., Gomez, I. G., Green, P. S., Hargarten, S., Gough, P. J., Parks, W. C., Wilson, C. L., Raines, E. W., & Heinecke, J. W. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800449-mcp200 · Cited by 91
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M., Gintz, M., Bellocq, J., & Rio, M. (2003) · PubMed · Cited by 88
Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition
Lauer‐Fields, J. L., Whitehead, J. K., Li, S., Hammer, R. P., Brew, K., & Fields, G. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801438200 · Cited by 85
Gene Transfer of Matrix Metalloproteinase-9 Induces Tumor Regression of Breast CancerIn vivo
Bendrik, C., Robertson, J. V., Gauldie, J., & Dabrosin, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0295 · Cited by 80
Cuadrado, E., Rosell, A., Borrell-Pagés, M., García‐Bonilla, L., Hernández‐Guillamón, M., Aznar, A. O., & Montaner, J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.130 · Cited by 75
Earlier Onset of Tumoral Angiogenesis in Matrix Metalloproteinase-19–Deficient Mice
Jost, M., Folgueras, A. R., Frérart, F., Pendás, A. M., Blacher, S., Houard, X., Berndt, S., Munaut, C., Cataldo, D. D., Álvarez, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4315 · Cited by 72
Lauer‐Fields, J. L., Brew, K., Whitehead, J. K., Li, S., Hammer, R. P., & Fields, G. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0715849 · Cited by 67
Keratinocyte Expression of MMP3 Enhances Differentiation and Prevents Tumor Establishment
McCawley, L. J., Wright, J., LaFleur, B., Crawford, H. C., & Matrisian, L. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080132 · Cited by 56
Identification of Pro-MMP-7 as a Serum Marker for Renal Cell Carcinoma by Use of Proteomic Analysis
Sarkissian, G., Fergelot, P., Lamy, P., Patard, J., Culine, S., Jouin, P., Rioux-Leclercq, N. C., & Darbouret, B. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.090837 · Cited by 48
Inhibition of MMP-2 gelatinolysis by targeting exodomain–substrate interactions
Xu, X., Chen, Z., Wang, Y., Bonewald, L. F., & Steffensen, B. (2007) · Biochemical Journal · doi:10.1042/bj20070591 · Cited by 46
Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter
Overall, C. M. (2004) · Biochemical Journal · doi:10.1042/bj20041433 · Cited by 45
Self-citationDeLassus, G. S., Cho, H., Park, J., & Eliceiri, G. L. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21548 · Cited by 45
Characterization of an exosite binding inhibitor of matrix metalloproteinase 13
Gooljarsingh, L. T., Lakdawala, A. S., Coppo, F. T., Luo, L., Fields, G. B., Tummino, P. J., & Gontarek, R. R. (2007) · Protein Science · doi:10.1110/ps.073130208 · Cited by 42
Synthetic active site-directed inhibitors of metzincins: Achievement and perspectives
Yiotakis, A., & Dive, V. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.06.001 · Cited by 39
Tailoring TIMPs for Selective Metalloproteinase Inhibition
Nagase, H., & Murphy, G. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_37 · Cited by 38
MMP Inhibitor Clinical Trials – The Past, Present, and Future
Fingleton, B. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_36 · Cited by 28
Functional genetic mouse models: promising tools for investigation of the proteolytic internet
Krüger, A. (2008) · Biological Chemistry · doi:10.1515/bc.2009.015 · Cited by 28
Cytokine Substrates: MMP Regulation of Inflammatory Signaling Molecules
Cox, J. H., & Overall, C. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_26 · Cited by 19
Self-citationThird-Generation MMP Inhibitors: Recent Advances in the Development of Highly Selective Inhibitors
Yiotakis, A., & Dive, V. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_38 · Cited by 11
Roy, M. V., Lint, P. V., Laere, I. V., Wielockx, B., Wilson, C. L., López-Otı́n, C., SHAPIRO, S. D., & Libert, C. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0016 · Cited by 9
Cited by
The impact of the extracellular matrix on inflammation
Sorokin, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2852 · Cited by 912
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Proteolytic networks in cancer
Mason, S. D., & Joyce, J. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.12.002 · Cited by 552
The tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
Hadler-Olsen, E., Winberg, J.-O., & Uhlin-Hansen, L. (2013) · Tumor Biology · doi:10.1007/s13277-013-0842-8 · Cited by 366
Metadata
- Authors
- Morrison, C. J., Butler, G. S., Rodríguez, D., & Overall, C. M.
- Venue
- Current Opinion in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 21
- Issue
- 5
- Pages
- 645-653
- ISSN
- 0955-0674 (ISSN-L)
- OpenAlex
- W2053559643
- Cited by
- 266
- References
- 70
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.